Skip to main content

Table 2 Response assessment.

From: Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis

 

No. of patients

%

Complete response

0

0

Partial response

44

52.4

Stable disease

37

44.0

Progressive disease

3

3.6

  1. The overall response rate was 52.4% (95% confidence interval, 42.9-64.5)
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us